z-logo
open-access-imgOpen Access
722 Review of The Introduction of Pre-Biopsy MRI Scanning in The Diagnostic Pathway for Prostate Cancer
Author(s) -
Akihiko SOMA
Publication year - 2021
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1093/bjs/znab259.096
Subject(s) - medicine , prostate cancer , referral , audit , biopsy , cancer , medical physics , radiology , general surgery , family medicine , management , economics
The diagnostic pathway for prostate cancer has changed recently with the introduction of a pre-biopsy MRI. This audit aims to identify whether this change helps the University Hospitals of Morecambe Bay NHS Foundation Trust meet the national standard of referral to treatment time of 62 days. Method This audit will follow the individual journeys of patients on the previous (05/2017 – 05/2018) and new pathway (08/2018 – 04/2019). In addition, they will be divided based on the treatment they chose – surgery or radiotherapy. Results Old pathway: New pathway: Conclusions Comparing the new pathway to the previous, there is a reduced proportion meeting the RTT. One way to combat this is ensuring patients have their MRI scans, if suitable, prior to their first clinic, which shows to be the most effective way to meet the RTT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom